CCRAN

Improving our readiness for genomic testing will be a game changer for people living with cancer – and our entire health system.

Canada has made some progress, but we’re far from ready. See how we can do better: accesstogenomictesting.ca

Have you or a loved one been diagnosed with colore**al cancer?

The University of Strathclyde is conducting research to explore the quality of life and psychological well-being among people diagnosed with colore**al cancer. As part of this study, patients are invited to share their experiences through an anonymous online survey and an optional follow-up interview.

Patients' unique perspectives can provide valuable insights that inform colore**al cancer care.

If this applies to you or someone you care for, we encourage you to reach out to learn about the study and how you could help.

Access the survey here: https://bit.ly/4x7wXhY

📧 [email protected]

**alCancer

CCRAN’s September newsletter is here! 📰

This month, we are reflecting on 20 years of support, education and advocacy while looking ahead to the work still to come.

Inside this issue:

• CCRAN celebrates its 20th anniversary
• The State of Readiness 2.0 report highlights gaps in access to genomic testing
• Registration opens for our 2026 Early Age Onset Cancer Symposium
• Free tools help colore**al cancer patients explore treatment options and manage side effects
• Upcoming education, advocacy and community outreach opportunities

Catch up on the latest news, resources and ways to get involved: https://bit.ly/4iCtzqp

**alCancer

Have you or a loved one been diagnosed with locally advanced re**al cancer?

Dostarlimab (JEMPERLI®) is anticipated to undergo a funding review in Canada for adults with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H), stage II/III, locally advanced re**al cancer. As part of this process, we invite patients and caregivers to share their experiences in a confidential 45-minute telephone interview.

You do not need to have received dostarlimab to take part — we want to hear from stage II or III re**al cancer patients at all stages of treatment, including those who were treated and later progressed.

Patient perspectives are crucial to helping decision-makers better understand the real-world impact of cancer and its treatments.

If this applies to you or someone you care for, we encourage you to reach out to learn more about how you can help.

Please contact Cassandra Macaulay at +1 833-792-2726 ext. 1001 or
[email protected] for more information.

**alCancer

Our September 2026 Colore**al Cancer Treatment and Clinical Research Updates are now available on the CCRAN website.

To explore new updates about treatment therapies, screening, and more, visit http://ccran.org/research-treatment-updates

**alCancer **alCancerSupport **alCancerAwareness

Join us for a special edition of CCRAN’s Monthly Information & Support Group meeting featuring Dr. Jill Shainhouse, a Toronto-based naturopathic doctor dedicated to supportive and integrative cancer care.

With more than 22 years of clinical experience, Dr. Shainhouse is a Fellow of the American Board of Naturopathic Oncology. She will present on supportive care for colore**al cancer and the integration of evidence-informed natural therapies with conventional cancer treatment.

CCRAN’s regular support group meeting will begin following her presentation, offering patients and caregivers an opportunity to connect and share in a welcoming space.

📅 Sunday, Sept. 20, 2026
⏰ 1 p.m. ET
💻 Online via Zoom

To RSVP and receive the Zoom details, email Himanshi Singhvi at [email protected].

**alCancer

Patient organizations are gathering input from patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) to inform a funding review of taletrectinib in Canada.

We are seeking patients or caregivers to complete a short confidential online survey about their experience with advanced or metastatic NSCLC and its treatments.

Patient perspectives play a critical role in helping decision-makers better understand the real-world impact of cancer and its treatments.

If this applies to you or someone you care for, we encourage you to participate and share your experience.

👉 To learn more or take part, please complete the survey here: https://www.surveymonkey.com/r/SM26_Ibtrozi_lung

Your voice can help shape others’ access to this therapy. 💙